GenePOC specializes in diagnostic devices for the prevention and detection of infectious diseases. The company aims to become the market leader in the rapid microbial testing. Its revogene instrument is also available in the US and EU markets with a rapidly expanding test menu.
GenePOC obtains FDA clearance for its GenePOC™ Carba test in the US
GenePOC, a subsidiary of Debiopharm Group, reaches an agreement with Meridian Bioscience for the acquisition of their molecular diagnostics business
The wonder of the revogene
GenePOC PIEs are single-use disposables to be used with the revogene instrument. Extraction, real-time PCR and detection are integrated providing results in 70 minutes.
Discover the members who guide and bring long-term vision to the company